News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
226,996 Results
Type
Article (5076)
Company Profile (18)
Press Release (221902)
Section
Business (82548)
Career Advice (462)
Deals (15075)
Drug Delivery (8)
Drug Development (19337)
Employer Resources (30)
FDA (3720)
Job Trends (3912)
News (120789)
Policy (7551)
Tag
Academia (303)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14935)
ALS (20)
Alzheimer's disease (249)
Antibody-drug conjugate (ADC) (11)
Approvals (3739)
Artificial intelligence (44)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2872)
Biosimilars (11)
Biotechnology (22)
Bladder cancer (17)
Brain cancer (7)
Breast cancer (50)
Cancer (476)
Cardiovascular disease (24)
Career advice (394)
Career pathing (3)
CAR-T (37)
Cell therapy (112)
Cervical cancer (2)
Clinical research (16189)
Collaboration (175)
Compensation (172)
Complete response letters (2)
COVID-19 (303)
CRISPR (9)
C-suite (112)
Cystic fibrosis (16)
Data (536)
Depression (7)
Diabetes (43)
Diagnostics (2052)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40996)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (38035)
Executive appointments (316)
FDA (3990)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (187)
Gene editing (20)
Generative AI (2)
Gene therapy (56)
GLP-1 (111)
Government (420)
Guidances (21)
Healthcare (5092)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (14)
Indications (6)
Infectious disease (319)
Inflammatory bowel disease (25)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7844)
IRA (3)
Job creations (1122)
Job search strategy (361)
Kidney cancer (7)
Labor market (5)
Layoffs (102)
Leadership (5)
Legal (2342)
Liver cancer (17)
Lung cancer (56)
Lymphoma (32)
Management (10)
Manufacturing (50)
MASH (29)
Medical device (3908)
Medtech (3909)
Mergers & acquisitions (7441)
Metabolic disorders (125)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (349)
NextGen: Class of 2025 (1681)
Non-profit (733)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (14)
Pancreatic cancer (15)
Parkinson's disease (29)
Partnered (4)
Patents (21)
Patient recruitment (35)
Peanut (5)
People (24698)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4849)
Phase II (7040)
Phase III (5582)
Pipeline (580)
Policy (9)
Postmarket research (626)
Preclinical (1984)
Press Release (66)
Prostate cancer (28)
Psychedelics (3)
Radiopharmaceuticals (106)
Rare diseases (70)
Real estate (1882)
Recruiting (8)
Regulatory (5168)
Reports (14)
Research institute (307)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (22)
Series A (28)
Series B (24)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1021)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (41)
Venture capitalists (2)
Weight loss (22)
Women's health (1)
Date
Today (53)
Last 7 days (251)
Last 30 days (733)
Last 365 days (9973)
2025 (3265)
2024 (11125)
2023 (13309)
2022 (18843)
2021 (19844)
2020 (18356)
2019 (13283)
2018 (10281)
2017 (10114)
2016 (9265)
2015 (12218)
2014 (9633)
2013 (7744)
2012 (8379)
2011 (8847)
2010 (8667)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (2)
Asia (11650)
Australia (1633)
California (2014)
Canada (725)
China (78)
Colorado (85)
Connecticut (97)
Delaware (30)
Europe (24858)
Florida (287)
Georgia (34)
Idaho (23)
Illinois (117)
India (7)
Indiana (64)
Iowa (2)
Japan (75)
Kansas (24)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1606)
Michigan (86)
Minnesota (141)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (579)
New Mexico (5)
New York (482)
North Carolina (335)
North Dakota (3)
Northern California (953)
Ohio (60)
Oklahoma (5)
Oregon (6)
Pennsylvania (362)
Puerto Rico (1)
Rhode Island (14)
South America (276)
South Carolina (6)
Southern California (730)
Tennessee (40)
Texas (233)
United States (7268)
Utah (63)
Virginia (47)
Washington D.C. (9)
Washington State (178)
West Virginia (2)
Wisconsin (25)
226,996 Results for "invivo corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia
April 28, 2025
·
7 min read
Biotech Beach
Turn Therapeutics Atopic Dermatitis Candidate Reduces Disease Severity by 57% In-Vivo
In a widely cited in-vivo model of atopic dermatitis, Turn Therapeutics’ atopic dermatitis candidate showed a dramatic reduction in disease severity versus placebo.
June 20, 2024
·
2 min read
Small Animal Imaging (In-Vivo) Market Expecting a Surge in Revenue of US$ 1,902 Million By 2032
The global small animal imaging (In-Vivo) market was valued at US$ 1,053 million in 2023.
May 2, 2024
·
7 min read
Deals
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Bruker Corporation announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems.
February 6, 2024
·
3 min read
Press Releases
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
December 10, 2024
·
3 min read
Press Releases
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
September 25, 2024
·
7 min read
Genetown
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced topline results from the company’s INSPIRE 2.0 study, which was designed to evaluate the safety and probable benefit of InVivo’s investigational Neuro-Spinal Scaffold™, a bioresorbable scaffold-based device in development for patients with acute SCI.
March 9, 2023
·
3 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Pharm Country
Nuvectis Pharma Announces a Publication in The Journal of Experimental Medicine for NXP900 in an In-Vivo Model of Metastatic Castration Resistant Prostate Cancer (“mCRPC”) with Acquired Resistance to Enzalutamide
Nuvectis Pharma, Inc. today announced a publication in the Journal of Experimental Medicine (“JEM”) for NXP900 in an in-vivo model of metastatic castration resistant prostate cancer.
February 9, 2023
·
4 min read
Press Releases
CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates
April 28, 2025
·
12 min read
1 of 22,700
Next
